{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:33:26Z","timestamp":1759962806890},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.ebcr.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T19:02:27Z","timestamp":1517943747000},"page":"1-3","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lacosamide-induced excessive laughing in a patient with Lennox\u2013Gastaut syndrome"],"prefix":"10.1016","volume":"10","author":[{"given":"Hussein","family":"Algahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader","family":"Shirah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad","family":"Algahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebcr.2018.01.001_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"16","author":"Baulac","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ebcr.2018.01.001_bb0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2008.01951.x","article-title":"Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial","volume":"50","author":"Hal\u00e1sz","year":"2009","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ebcr.2018.01.001_bb0015","article-title":"Lacosamide add-on therapy for partial epilepsy","author":"Weston","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebcr.2018.01.001_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fneur.2017.00505","article-title":"Expert opinion on the management of Lennox\u2013Gastaut syndrome: treatment algorithms and practical considerations","volume":"8","author":"Cross","year":"2017","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.ebcr.2018.01.001_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.17712\/nsj.2015.3.20140677","article-title":"Lennox\u2013Gastaut syndrome. Management update","volume":"20","author":"Al-banji","year":"2015","journal-title":"Neurosciences (Riyadh)"},{"issue":"55 Suppl","key":"10.1016\/j.ebcr.2018.01.001_bb0030","first-page":"4:4","article-title":"Lennox\u2013Gastaut syndrome: a consensus approach to differential diagnosis","author":"Bourgeois","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2018.01.001_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.seizure.2015.04.003","article-title":"Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: a multicenter evaluation","volume":"29","author":"Gir\u00e1ldez","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.ebcr.2018.01.001_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yebeh.2016.10.029","article-title":"Long-term lacosamide retention-Real-world experience at a tertiary epilepsy center in Ireland","volume":"68","author":"Mcginty","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.ebcr.2018.01.001_bb0045","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1111\/ane.12254","article-title":"Efficacy and tolerability of add-on lacosamide in children with Lennox\u2013Gastaut syndrome","volume":"130","author":"Grosso","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.ebcr.2018.01.001_bb0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0163-8343(97)00023-6","article-title":"Medical evaluation of persons with mental retardation referred for psychiatric assessment","volume":"19","author":"Ryan","year":"1997","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"10.1016\/j.ebcr.2018.01.001_bb0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WNF.0000000000000097","article-title":"Lacosamide induced psychosis: case report, review of differential diagnosis and relevant pharmacokinetics","volume":"38","author":"Pinkhasov","year":"2015","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ebcr.2018.01.001_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1752-1947-7-123","article-title":"Laugh-induced seizure: a case report","volume":"7","author":"Mainali","year":"2013","journal-title":"J Med Case Reports"},{"issue":"Pt 4","key":"10.1016\/j.ebcr.2018.01.001_bb0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/brain\/116.4.757","article-title":"Mirth, laughter and gelastic seizures","volume":"116","author":"Arroyo","year":"1993","journal-title":"Brain"},{"issue":"1\u20133","key":"10.1016\/j.ebcr.2018.01.001_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.09.050","article-title":"The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents","volume":"624","author":"Higgins","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.ebcr.2018.01.001_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yebeh.2012.02.013","article-title":"The gelastic seizures\u2013hypothalamic hamartoma syndrome: facts, hypotheses, and perspectives","volume":"24","author":"Striano","year":"2012","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323217301639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323217301639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T18:17:31Z","timestamp":1542651451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213323217301639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":15,"alternative-id":["S2213323217301639"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2018.01.001","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lacosamide-induced excessive laughing in a patient with Lennox\u2013Gastaut syndrome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}